Immunohematology Market Analysis by Product (Immunohematology Analyzer, Immunohematology Reagent), By End Use (Hospitals, Blood banks, Diagnostic Laboratories), By Region (North America, Europe, APAC, LATAM & MEA) And Segment Forecasts, 2013 - 2024

  • ID: 3989908
  • Report
  • Region: America, Europe, North America, United States
  • 120 pages
  • Grand View Research
1 of 3
The global immunohematology market is expected to reach a value of USD 2.3 billion by 2024. This expansion is attributed to the increasing cases of trauma and rising number of hospital and trauma care centers facilitating emergency treatments. This creates a need to procure blood to suffice the demand, thus, boosting the market for immunohematology tests and products.Involvement of government organizations and NGOs is vast in this field.

Use of technology is contributing to the growth in the market. Use of mobile applications helps in tracking the blood donation activity of volunteer donors and also reminds them to donate regularly. In April 2016, The Indian Red Cross Society launched an application (app) to facilitate blood banking facility. The app is expected to address the shortage issue in the region. Moreover, in 2011, the first type of this application was launched by Hemo bioscience, Inc., a U.S.-based company. The company made the app available for free for apple users.

Further Key Findings From the Study Suggest:

Immunohematology reagents dominated the product segment in 2015 due to huge product variety and an increasing number of blood banks procuring these reagents. The innovations in the field are resulting in new product launches and also the efforts are acknowledged at a global level.

In December 2013, Sysmex Corporation received the German Design Award for its XN-2000 hematology reagent. Almost 1,900 products were nominated for the award.

Hospitals dominated the end-use segment in 2015 due to increasing number of emergency cases because of road accidents and other types of trauma. Governments and investors are increasingly investing in expanding and upgrading emergency departments in hospitals to cater to the growing demand and increase the chances of survival of trauma patients.

In 2015, North America dominated the market with a revenue share of more than 40%. In the U.S., there is a patient requiring transfusion every 2 seconds. The daily consumption of blood is approximately 36,000 units per day. This indicates the huge opportunity of growth in this region.

Some of the key industry players are Hologic, Inc., Bio-Rad Laboratories, Inc.; Grifols, ThermoFisher, Immucor; Ortho Clinical Diagnostics; BD (Becton Dickinson); Siemens Healthcare GmbH; Abbott; and Beckman Coulter, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
2 Executive Summary
2.1 Market Snapshot
3 Market Variables, Trends& Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing rate of trauma injuries
3.1.1.2 Industry players introducing new products
3.1.1.3 Rising prevalence of target diseases
3.1.2 Market restraint analysis
3.1.2.1 High cost of products
3.2 Penetration & Growth Prospects Mapping
3.3 Immunohematology Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
3.5 Competitive landscape: Market position analysis (based on products, regional presence and strategic initiatives)
4 Immunohematology Market Product Estimates & Trend Analysis
4.1 Immunohematology Market: Product Movement Analysis
4.2 Immunohematology analyzer
4.2.1 Immunohematology analyzer market estimates and forecasts, 2013 - 2024 (USD Million)
4.3 Immunohematology reagent
4.3.1 Immunohematology reagent market estimates and forecasts, 2013 - 2024 (USD Million)
5 Immunohematology Market End-Use Estimates & Trend Analysis
5.1 Immunohematology Market: End-Use Movement Analysis
5.2 Hospitals
5.2.1 Hospitals market estimates and forecasts, 2013 - 2024 (USD Million)
5.3 Blood banks
5.3.1 Blood banks market estimates and forecasts, 2013 - 2024 (USD Million)
5.4 Diagnostic laboratories
5.4.1 Diagnostic laboratories market estimates and forecasts, 2013 - 2024 (USD Million)
6 Immunohematology Market: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2015 & 2024
6.2 North America
6.2.1 North America immunohematology market, by product, 2013 - 2024 (USD Million)
6.2.2 North America immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. immunohematology market, by product, 2013 - 2024 (USD Million)
6.2.3.2 U.S. immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.2.4 Canada
6.2.4.1 Canada immunohematology market, by product, 2013 - 2024 (USD Million)
6.2.4.2 Canada immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.3 Europe
6.3.1 Europe immunohematology market, by product, 2013 - 2024 (USD Million)
6.3.2 Europe immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.3.3 Germany
6.3.3.1 Germany immunohematology market, by product, 2013 - 2024 (USD Million)
6.3.3.2 Germany immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.3.4 UK
6.3.4.1 UK immunohematology market, by product, 2013 - 2024 (USD Million)
6.3.4.2 UK immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific immunohematology market, by product, 2013 - 2024 (USD Million)
6.4.2 Asia Pacific immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.4.3 Japan
6.4.3.1 Japan immunohematology market, by product, 2013 - 2024 (USD Million)
6.4.3.2 Japan immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.4.4 China
6.4.4.1 China immunohematology market, by product, 2013 - 2024 (USD Million)
6.4.4.2 China immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.4.5 India
6.4.5.1 India immunohematology market, by product, 2013 - 2024 (USD Million)
6.4.5.2 India immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America immunohematology market, by product, 2013 - 2024 (USD Million)
6.5.2 Latin America immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil immunohematology market, by product, 2013 - 2024 (USD Million)
6.5.3.2 Brazil immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico immunohematology market, by product, 2013 - 2024 (USD Million)
6.5.4.2 Mexico immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.6 MEA
6.6.1 MEA immunohematology market, by product, 2013 - 2024 (USD Million)
6.6.2 MEA immunohematology market, by end-use, 2013 - 2024 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa immunohematology market, by product, 2013 - 2024 (USD Million)
6.6.3.2 South Africa immunohematology market, by end-use, 2013 - 2024 (USD Million)
7 Competitive Landscape
7.1 Strategy framework
7.2 Company Profiles
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Immucor
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Grifols
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 BD (Becton Dickinson)
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives
7.7 Hologic, Inc.
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Siemens Healthcare GmbH
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic Initiatives
7.9 ThermoFisher
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 Abbott
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
7.11 Beckman Coulter, Inc.
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Product benchmarking
7.11.4 Strategic initiatives
7.12 Roche Diagnostics Corporation
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic initiatives

List of Tables

Table 1 Immunohematology - global market current and forecast by regions (2015-2024) in (USD Million)
Table 2 North America immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
Table 3 North America immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 4 North America immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 5 U.S. immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 6 U.S. immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 7 Canada immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 8 Canada immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 9 Europe immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
Table 10 Europe immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 11 Europe immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 12 UK immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 13 UK immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 14 Germany immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 15 Germany immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 16 Asia Pacific immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
Table 17 Asia Pacific immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 18 Asia Pacific immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 19 Japan immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 20 Japan immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 21 China immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 22 China immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 23 India immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 24 India immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 25 Latin America immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
Table 26 Latin America immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 27 Latin America immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 28 Brazil immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 29 Brazil immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 30 Mexico immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 31 Mexico immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 32 MEA immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
Table 33 MEA immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 34 MEA immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
Table 35 South Africa immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
Table 36 South Africa immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value Chain Based Sizing & Forecasting
Figure 6 QFD Modeling For Market Share Assessment
Figure 7 Market Summary
Figure 8 Market Trends & Outlook
Figure 9 Market Segmentation & Scope
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 Penetration & Growth Prospect Mapping
Figure 13 Immunohematology market - PESTLE Analysis
Figure 14 Porter’s Five Forces Analysis
Figure 15 Immunohematology market product outlook key takeaways
Figure 16 Immunohematology market: Product movement analysis
Figure 17 Global immunohematology market, by product 2013 - 2024 (USD Million)
Figure 18 Global immunohematology analyzer market, 2013 - 2024 (USD Million)
Figure 19 Global immunohematology reagent market, 2013 - 2024 (USD Million)
Figure 20 Global immunohematology market, by end-use, 2013 - 2024 (USD Million)
Figure 21 Global hospital market, 2013 - 2024 (USD Million)
Figure 22 Global blood bank market, 2013 - 2024 (USD Million)
Figure 23 Global diagnostic laboratories market, 2013 - 2024 (USD Million)
Figure 24 Regional market place: Key takeaways
Figure 25 Immunohematology market regional outlook, 2015 & 2024
Figure 26 North America immunohematology market, 2013 - 2024 (USD Million)
Figure 27 U.S. immunohematology market, 2013 - 2024 (USD Million)
Figure 28 Canada immunohematology market, 2013 - 2024 (USD Million)
Figure 29 Europe immunohematology market, 2013 - 2024 (USD Million)
Figure 30 Germany immunohematology market, 2013 - 2024 (USD Million)
Figure 31 UK immunohematology market, 2013 - 2024 (USD Million)
Figure 32 Asia Pacific immunohematology market, 2013 - 2024 (USD Million)
Figure 33 Japan immunohematology market, 2013 - 2024 (USD Million)
Figure 34 China immunohematology market, 2013 - 2024 (USD Million)
Figure 35 India immunohematology market, 2013 - 2024 (USD Million)
Figure 36 Latin America immunohematology market, 2013 - 2024 (USD Million)
Figure 37 Brazil immunohematology market, 2013 - 2024 (USD Million)
Figure 38 Mexico immunohematology market, 2013 - 2024 (USD Million
Figure 39 Middle East immunohematology market, 2013 - 2024 (USD Million)
Figure 40 South Africa immunohematology market, 2013 - 2024 (USD Million)
Figure 41 Strategy framework
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll